Yasmina Abdiche

Chief Scientific Officer at ImmunoPrecise Antibodies

Dr. Yasmina Abdiche joined ImmunoPrecise Antibodies in April 2020 as Chief Scientific Officer (CSO) and leads the company's global research and development team. She was previously CSO at Carterra, where she helped to transition the LSA antibody screening technology from concept to global commercialization. Prior to that, she had a twelve-year career at Rinat, Pfizer's biotherapeutic site, where she led a core team of analytical scientists performing antibody characterization on label-free biosensors.

As a Research Fellow, she also served on Rinat's Leadership Team and on the Governing Committee for Pfizer's Post-doctoral Program. She holds over twelve issued patents in the antibody space and is co-inventor of a PD-1 inhibitor (Sasanlimab, PF06801591, RN888) currently in clinical trials for various cancer types and of a market-approved anti-CGRP antibody for migraine, Ajovy. Dr. Abdiche graduated from Oxford University in the UK with a Master's degree in Chemistry and a Ph.D. in Biological Chemistry.

She has co-authored over 45 peer-reviewed publications in the application of label-free biosensors to drug discovery and has given numerous invited presentations at scientific conferences worldwide.